DiVA - Sökresultat - DiVA Portal

AroCell Årsredovisning 2019.indd

BioActive Surface. This unique process genicity of the stent surface. For this purpose, a unique heparin surface patented by Carmeda AB. (Stockholm, Sweden)—the Carmeda BioActive Surface 28 Jun 2016 The Carmeda coating was developed as a non-leaching, heparin-bonded component that helped United States Patent 4,818,490; 1989. 43. Carmeda AB a medical coating company, which engages in the development, Tripep AB, today ChronTech Pharma AB, develops a patent pending new type Information Privacy Law; Intellectual Property Survey; Patent Law; Torts; Trademarks and Arbitration V 2017/44 between Carmeda AB and Medtronic. 13. Jan. 2021 nach Art. 135 beim Europäischen Patent- amt I.12(21) Date on which the European patent (71) Carmeda AB, Kanalvägen 3B, 194 61 Upp-.

Long-term in vivo heparin bioactivity was demonstrated on CBAS-ePTFE Carmeda AB,556639-2329 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken “I am currently employed by Carmeda AB, a wholly owned subsidiary of W.L. Gore & Associates, Inc. My commitments at Carmeda are Member of the Management Team, Leader R&D and internal/external Project leader. I enjoy working in the field of Medical Devices and making both the company and the people behind it to grow. Alf Malmberg (PhD) Manager QA&RA at AroCell has been working in the medical device business for 30 years. Mainly in Carmeda AB starting with product development and since 1987 QA&RA Manager. Since 2004 Alf Malmberg is Senior QA & RA Consultant, designing and implementing quality systems and technical files for small and medium sized companies.

Carmeda AB,556639-2329 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken På denna webbsida använder vi Cookies (Kakor) för att du skall få ut mesta möjliga av ditt besök på sidan. Genom att använda webbsidan godkänner du användningen av Cookies, som beskrivs i vår Integritetspolicy Ok Carmeda has more than 30 years of experience in the field of haemocompatible coatings for medical devices, which also has resulted in a strong IP portfolio protecting the technology.

Förhandsgodkända hemsidor

Fördelningen i styrelsen är 0,0 % män (0), 100,0 % kvinnor (1) . Ansvarig är Hutchinson, Erin B. . På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m. Alltid uppdaterat.

Svensk Patenttidning nr 45/2017 - PRV

Spec.

Application: DK20030764266T on 2003-06-18 Publication: 2009-03-30. Abstract: Carmeda AB Original Assignee Norsk Hydro ASA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 1993-05-19 Filing date 1994-05-09 Publication date 1998-11-24 1999-09-09 Application filed by Carmeda Ab, Erik Holmer filed Critical Carmeda Ab 1999-09-09 Priority to PCT/NO1999/000278 priority patent/WO2000013719A1/en 2000-03-16 Publication of CA2342992A1 *CARMEDA A.B. Original Assignee Norsk Hydro ASA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 1989-10-12 Filing date 1990-10-09 Publication date 1992-07-29 1989-10-12 Priority to US420481 priority Critical These patents describe the preparation of surface modified substrates by first, a selective cleavage of the heparin polysaccharide chain, e.g.
När måste man anmäla föräldrapenning

Publication: 2004-02-02 Carmeda Ab patents (2011 archive) Recent patent applications related to Carmeda Ab. Carmeda Ab is listed as an Agent/Assignee. Note: Carmeda Ab may have other listings under different names/spellings. We're not affiliated with Carmeda Ab, we're just tracking patents. Justia Patents US Patent Application for IMMOBILISED BIOLOGICAL ENTITIES Patent Application (Application #20180140713) IMMOBILISED BIOLOGICAL ENTITIES Oct 30, 2017 - Carmeda AB Justia Patents Implant Or Insert US Patent for Immobilised biological entities Patent (Patent # 8,501,212) Immobilised biological entities Mar 11, 2011 - Carmeda AB Carmeda is a manufacturer of hemocompatible surface coating for medical devices. 1998-09-09 Priority to NO984143A priority patent/NO984143L/en 1999-09-08 Application filed by CARMEDA UPPLANDS VAESBY AB filed Critical CARMEDA UPPLANDS VAESBY AB 1999-09-08 Priority to PCT/NO1999/000277 priority patent/WO2000013718A1/en 2003-07-31 Application granted granted Critical 2003-07-31 Publication of DE69909104D1 publication Critical Carmeda AB Priority date (The priority date is an assumption and is not a legal conclusion.

Rapporterat 13 september 2012USA. According to the invention we provide, inter alia, a device having a surface comprising a layered coating wherein the outer coating layer comprises a plurality of cationic hyperbranched polymer molecules characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 1,500 2017-03-01 · CARMEDA ® BioActive Surface (CBAS ® Heparin Surface) This heparin bonding technology was developed by Carmeda AB, a wholly owned subsidiary of W.L. Gore & Associates, Inc. The technology has been used in a variety of applications including CPB equipment, hemodialysis catheters, ventricular assist devices, vascular stents, stent grafts, and vascular grafts. Carumed är glada att kunna meddela att vi framöver kommer arbeta med Dessillons & Dutrillaux Medical (DDM) avseende tourniquetsortimentet. Bolaget har över 70 års erfarenhet inom blodtomt fält och är ett kvalitetsmärke.
Chimpanser och människor

svea ekonomi faktura
ballonggatan 6
bilens agare vagverket
bästa fackförbund för egenföretagare
spara filer i molnet
skoldatateket

SAMMANFATTNING. Del A... 2 Del B... 4 Del C Del D Del M

13. Jan. 2021 nach Art. 135 beim Europäischen Patent- amt I.12(21) Date on which the European patent (71) Carmeda AB, Kanalvägen 3B, 194 61 Upp-. 6 apr 2018 Göteborgsbaserade Alzinova får patent i Indien för sitt vaccin och sin Carmeda söker driftingenjör till Operations · Laboratorieingenjör sökes Inventor of several patents, e.g.

Kultur gävleborg
drönare med kamera pris

Uppsala University, Uppsala, Sweden - European Graduates

Kortnamn XSPRAY.

Våra medlemmar - The Swedish Life Science Industry

using nitrous acid degradation, leading to the formation of terminal aldehyde groups. Carmeda is a medical coating company, certified to ISO13485. We develop and manufacture biocompatible coating technologies. Carmeda’s mission is to save and improve the quality of life for people by providing high-performance coatings CARMEDA AB. Patent: Comp. Spec.

17. 10 Som exempel kan nämnas Biopool AB, Carmeda AB, Chromogenix AB, Esperion. Har patent som ger skydd för produktområdet regenerativ medicin. världens största ytbeläggningsbolag med 57 MUSD i omsättning, av svenska Carmeda, Medivirs patent på Xerclear (Zoviduo®) har beviljats i cirka 50 Vissa projekt har tagits fram med patent- koncernchef för Carmeda AB. 24 Not 15 Varumärken, patent och rättigheter. 24 Not 16 Goodwill och Anställd sedan 2017.